Alicia J. Hager

Companies

• Nkarta Therapeutics (United States)General counsel Oct 28, 2020 to now¹
• OncoMedGeneral counsel Jul 17, 2013 to Apr 23, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNkarta Therapeutics (United States) NKTX146,735 shares³$261.9K at $1.78Jan 15, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 15, 2025Sold 9,584 shares at $2.20 of Nkarta Therapeutics (United States)³
• Jan 3, 2025Granted 52,500 shares of Nkarta Therapeutics (United States)⁴
• Jul 16, 2024Sold 3,396 shares at $8.00 of Nkarta Therapeutics (United States)⁵
• Jun 18, 2024Sold 727 shares at $5.60 of Nkarta Therapeutics (United States)⁶
• Jan 16, 2024Sold 4,554 shares at $8.74 of Nkarta Therapeutics (United States)⁷
• Jan 4, 2024Granted 56,000 shares of Nkarta Therapeutics (United States)⁸
• Jun 20, 2023Sold 701 shares at $4.85 of Nkarta Therapeutics (United States)⁹
• Jan 17, 2023Sold 1,103 shares at $5.49 of Nkarta Therapeutics (United States)¹⁰
• Jan 13, 2023Granted 37,500 shares of Nkarta Therapeutics (United States)¹⁰
• Jun 17, 2022Granted 8,000 shares of Nkarta Therapeutics (United States)¹¹
• Jan 14, 2022Granted 12,800 shares of Nkarta Therapeutics (United States)¹²